King, Andrew J.
Songdej, Duantida http://orcid.org/0000-0002-5750-7211
Downes, Damien J. http://orcid.org/0000-0002-5034-0869
Beagrie, Robert A. http://orcid.org/0000-0003-1076-5595
Liu, Siyu
Buckley, Megan http://orcid.org/0000-0003-4450-8474
Hua, Peng http://orcid.org/0000-0003-3774-5033
Suciu, Maria C.
Marieke Oudelaar, A. http://orcid.org/0000-0002-4016-6158
Hanssen, Lars L. P.
Jeziorska, Danuta
Roberts, Nigel http://orcid.org/0000-0002-5091-3604
Carpenter, Stephanie J.
Francis, Helena http://orcid.org/0000-0002-0184-7890
Telenius, Jelena
Olijnik, Aude-Anais
Sharpe, Jacqueline A.
Sloane-Stanley, Jacqueline
Eglinton, Jennifer
Kassouf, Mira T.
Orkin, Stuart H. http://orcid.org/0000-0002-0313-152X
Pennacchio, Len A. http://orcid.org/0000-0002-8748-3732
Davies, James O. J.
Hughes, Jim R. http://orcid.org/0000-0002-8955-7256
Higgs, Douglas R. http://orcid.org/0000-0003-3579-8705
Babbs, Christian http://orcid.org/0000-0002-1898-5878
Funding for this research was provided by:
Wellcome Trust (108785/Z/15/Z, 106130/Z/14/Z, 106130/Z/14/Z)
RCUK | Medical Research Council (MC_uu_12009)
Article History
Received: 4 September 2020
Accepted: 12 June 2021
First Online: 21 July 2021
Competing interests
: J.R.H. and J.O.J.D. are founders and shareholder of Nucleome Therapeutics and D.J.D. is a paid consultant for Nucleome Therapeutics. Other authors declare no competing interests.